Rivastigmine as treatment for patients with mild to moderately severe Alzheimer disease under normal clinical practice conditions. The ENTERPRISE study

Statistics

Original article

Manejo terapéutico con rivastigmina en pacientes con enfermedad de Alzheimer de leve a moderadamente grave en condiciones de práctica clínica habitual. Estudio ENTERPRISE

A.J. Cruz Jentofta,

Corresponding author

alfonsojose.cruz@salud.madrid.org

Corresponding author.

, B. Hernándezb

a Servicio de Geriatría, Hospital Universitario Ramón y Cajal, Madrid, Spain

b Novartis Farmacéutica, S.A., Barcelona, Spain

Read

3732

Times
was read the article

1126

Total PDF

2606

Total HTML

Share statistics

Article information

ISSN: 21735808
Original language: English

DOI:10.1016/j.nrleng.2013.01.002

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 July	1	0	1
2024 June	27	16	43
2024 May	8	10	18
2024 April	31	5	36
2024 March	36	13	49
2024 February	29	10	39
2024 January	25	10	35
2023 December	54	13	67
2023 November	32	17	49
2023 October	32	7	39
2023 September	14	10	24
2023 August	12	7	19
2023 July	10	11	21
2023 June	17	3	20
2023 May	24	5	29
2023 April	21	4	25
2023 March	13	7	20
2023 February	15	5	20
2023 January	27	7	34
2022 December	12	2	14
2022 November	13	11	24
2022 October	21	5	26
2022 September	17	8	25
2022 August	17	13	30
2022 July	23	7	30
2022 June	17	12	29
2022 May	22	6	28
2022 April	36	7	43
2022 March	22	7	29
2022 February	15	11	26
2022 January	11	10	21
2021 December	10	6	16
2021 November	22	10	32
2021 October	25	10	35
2021 September	14	10	24
2021 August	28	14	42
2021 July	17	10	27
2021 June	13	9	22
2021 May	18	2	20
2021 April	28	14	42
2021 March	16	17	33
2021 February	14	8	22
2021 January	19	10	29
2020 December	16	8	24
2020 November	18	6	24
2020 October	27	8	35
2020 September	22	10	32
2020 August	19	9	28
2020 July	9	10	19
2020 June	13	7	20
2020 May	11	11	22
2020 April	17	6	23
2020 March	26	8	34
2020 February	21	6	27
2020 January	20	21	41
2019 December	25	8	33
2019 November	14	11	25
2019 October	11	7	18
2019 September	20	13	33
2019 August	17	5	22
2019 July	18	11	29
2019 June	31	18	49
2019 May	68	42	110
2019 April	44	30	74
2019 March	11	9	20
2019 February	20	10	30
2019 January	15	8	23
2018 December	19	13	32
2018 November	32	14	46
2018 October	31	14	45
2018 September	26	7	33
2018 August	20	8	28
2018 July	7	15	22
2018 June	12	7	19
2018 May	11	8	19
2018 April	7	6	13
2018 March	6	1	7
2018 February	12	1	13
2018 January	6	5	11
2017 December	13	3	16
2017 November	16	3	19
2017 October	17	6	23
2017 September	22	5	27
2017 August	22	6	28
2017 July	14	3	17
2017 June	18	13	31
2017 May	15	14	29
2017 April	20	3	23
2017 March	12	37	49
2017 February	10	3	13
2017 January	13	1	14
2016 December	22	4	26
2016 November	34	6	40
2016 October	28	7	35
2016 September	24	3	27
2016 August	18	8	26
2016 July	19	3	22
2016 June	33	8	41
2016 May	37	16	53
2016 April	26	30	56
2016 March	27	15	42
2016 February	44	15	59
2016 January	14	4	18
2015 December	28	11	39
2015 November	21	4	25
2015 October	26	3	29
2015 September	23	9	32
2015 August	39	9	48
2015 July	29	10	39
2015 June	11	8	19
2015 May	32	4	36
2015 April	26	17	43
2015 March	28	8	36
2015 February	14	6	20
2015 January	37	12	49
2014 December	35	11	46
2014 November	25	6	31
2014 October	32	7	39
2014 September	27	0	27
2014 August	19	7	26
2014 July	9	1	10
2014 June	8	2	10
2014 May	5	3	8
2014 April	5	1	6
2014 March	15	5	20
2014 February	14	6	20

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter